Secondary medical prevention after primary vascular surgery between 1996 and 2006: A shift towards more evidence-based treatment

European Journal of Preventive Cardiology

Volumn 20, Issue 5, 2013, Pages 763-770

  Høgh, Annette ^a,b   Lindholt, Jes S ^a   Nielsen, Henrik ^b   Jensen, Leif P ^c   Johnsen, Søren P ^b  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

Nationwide follow up study; peripheral arterial disease; secondary medical prevention; vascular surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; DENMARK; DRUG USE; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY PREVENTION; VASCULAR SURGERY;

NATIONWIDE FOLLOW UP STUDY; PERIPHERAL ARTERIAL DISEASE; SECONDARY MEDICAL PREVENTION; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DENMARK; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RECURRENCE; REGISTRIES; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84884150399     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312449592     Document Type: Article

References (26)

1. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996 ; 94: 3026-3049
2. Alzamora MT, Baena-Diez JM, Sorribes M, et al. Peripheral Arterial Disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality. BMC Public Health. 2007 ; 7: 348-348
3. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med. 1998 ; 3: 241-245
4. Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008 ; 51: 1588-1596
5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45: S5 - S67
6. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 ; 113: e463 - e654
7. De BG, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss. 2004 ; 97: 1019-1030
8. Schroder TV, Ebskov LB, Egeblad M, et al. A consensus report from the Danish Medical association. Ugeskr Laeger 2005. ISSN: 1398-1560.
9. Aronow WS, Ahmed MI, Ekundayo OJ, et al. A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. Am J Cardiol. 2009 ; 103: 130-135
10. Flu HC, Tamsma JT, Lindeman JH, et al. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg. 2010 ; 39: 70-86
11. Gasse C, Jacobsen J, Larsen AC, et al. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction. Eur J Vasc Endovasc Surg. 2008 ; 35: 51-58
12. Khan S, Flather M, Mister R, et al. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg. 2007 ; 33: 442-450
13. Rice TW, Lumsden AB. Optimal medical management of peripheral arterial disease. Vasc Endovascular Surg. 2006 ; 40: 312-327
14. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295: 180-189
15. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 39-46
16. Laustsen J, Jensen LP, Hansen AK. Accuracy of clinical data in a population based vascular registry. Eur J Vasc Endovasc Surg. 2004 ; 27: 216-219
17. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006 ; 53: 441-449
18. Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser. 1993 ; 45: 55-78
19. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999 ; 46: 263-268
20. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 ; 40: 373-383
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 ; 45: 613-619
22. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000 ; 31: S1 - S296
23. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004 ; 159: 702-706
24. Cummings P. Re: 'Estimating the relative risk in cohort studies and clinical trials of common outcomes'. Am J Epidemiol. 2004 ; 159: 213-215
25. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993 ; 342: 1317-1322
26. Nickelsen TN. [Data validity and coverage in the Danish National Health Registry. A literature review]. Ugeskr Laeger. 2001 ; 164: 33-37